Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed sus
3 Dividend Stocks to Hold Through Market Volatility This Fall
04:21pm, Tuesday, 16'th Sep 2025
Stocks are rallying on the expectation that the Federal Reserve will cut interest rates by 25 basis points in September. That should be positive for corporate earnings.
Josh Brown's Best Stocks in the Market: Johnson & Johnson
01:23pm, Tuesday, 16'th Sep 2025
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to explain why he's adding Johnson & Johnson to his "best stocks in the market"
Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting
08:00am, Monday, 15'th Sep 2025
21 abstracts from across the Company's portfolio highlight clinical and real-world data on major depressive disorder, treatment-resistant depression and schizophrenia New Phase 3 data demonstrate the
If You'd Invested $1,000 in Johnson & Johnson (JNJ) Stock 5 Years Ago, Here's How Much You'd Have Today
05:19am, Monday, 15'th Sep 2025
How much would your $1,000 investment be worth if you'd bought Johnson & Johnson (JNJ -0.23%) five years ago? It would be worth $1,359.
COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says
01:37pm, Friday, 12'th Sep 2025
Shares of companies that make COVID vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths.
JNJ Seeks EU Approval for Oral Psoriasis Drug Icotrokinra
12:40pm, Friday, 12'th Sep 2025
J&J seeks EMA's nod to icotrokinra for treating plaque psoriasis in adults and pediatric patients aged 12 years and older.
J&J Painting Recognized with 2026 Consumer Choice Award for Painting Contractor in Waterloo
06:00am, Friday, 12'th Sep 2025
WATERLOO, ON / ACCESS Newswire / September 12, 2025 / J&J Painting, a trusted name in residential and commercial painting services, has been recognized with the 2026 Consumer Choice Award in the Paint
After a couple years in purgatory, Johnson & Johnson is now having a strong year, says Jim Cramer
08:15pm, Thursday, 11'th Sep 2025
'Mad Money' host Jim Cramer revisits Johnson & Johnson's stock after a rough year for healthcare.
Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing
06:45pm, Thursday, 11'th Sep 2025
In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $178.41, denoting a +1.49% move from the preceding trading day.
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:00am, Thursday, 11'th Sep 2025
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor. 1
Johnson & Johnson (JNJ) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
02:55pm, Wednesday, 10'th Sep 2025
Johnson & Johnson (NYSE:JNJ ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants Joaquin Duato - CEO & Chairman John Reed - Executive Vice Pre
5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds
12:11pm, Wednesday, 10'th Sep 2025
In the Large-Cap Pharmaceuticals industry, Lilly, J&J, Novartis, Pfizer and Bayer are worth retaining amid macro pressure and rising innovation.
J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum
12:06pm, Wednesday, 10'th Sep 2025
J&J secures FDA approval for Inlexzoh, which boosts its Innovative Medicine pipeline and reinforces long-term growth momentum.
